Heart disease and stroke statistics—2022 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, A Alonso… - Circulation, 2022 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks

W Wang, CY Wang, SI Wang, JCC Wei - EClinicalMedicine, 2022 - thelancet.com
Background The long-term cardiovascular outcomes in COVID-19 survivors remain largely
unclear. The aim of this study was to investigate the long-term cardiovascular outcomes in …

Post-acute COVID-19 syndrome

D Montani, L Savale, N Noel… - European …, 2022 - Eur Respiratory Soc
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the coronavirus disease 2019 (COVID-19) pandemic that has resulted in …

CT of post-acute lung complications of COVID-19

JJ Solomon, B Heyman, JP Ko, R Condos, DA Lynch - Radiology, 2021 - pubs.rsna.org
The acute course of COVID-19 is variable and ranges from asymptomatic infection to
fulminant respiratory failure. Patients recovering from COVID-19 can have persistent …

Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales

R Knight, V Walker, S Ip, JA Cooper, T Bolton… - Circulation, 2022 - Am Heart Assoc
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

DM Smadja, SJ Mentzer, M Fontenay, MA Laffan… - Angiogenesis, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …

Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection

D McGonagle, G De Marco, C Bridgewood - Journal of autoimmunity, 2021 - Elsevier
Herein, we consider venous immunothrombotic mechanisms in SARS-CoV-2 infection and
anti-SARS-CoV-2 DNA vaccination. Primary SARS-CoV-2 infection with systemic viral RNA …

SARS-CoV-2 B. 1.1. 7 (alpha) and B. 1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains

P Radvak, HJ Kwon, M Kosikova… - Nature …, 2021 - nature.com
SARS-CoV-2 variants of concern (VOC) B. 1.1. 7 (alpha) and B. 1.351 (beta) show increased
transmissibility and enhanced antibody neutralization resistance. Here we demonstrate in …

Current and emerging knowledge in COVID-19

YJ Jeong, YM Wi, H Park, JE Lee, SH Kim, KS Lee - Radiology, 2023 - pubs.rsna.org
COVID-19 has emerged as a pandemic leading to a global public health crisis of
unprecedented morbidity. A comprehensive insight into the imaging of COVID-19 has …